Viking Therapeutics, Inc.

VKTX

$35.56

Name : Viking Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $4,427,578,368.00

EPSttm : -4.67

Viking Therapeutics, Inc.

$35.56

3.24%

$1.19

VKTX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

EPS Last/This Y

-1.42

EPS This/Next Y

0.2

Price

35.54

Target Price

95.67

Analyst Recom

1.2

Performance Q

-6.52

Upside

-270.4%

Beta

0.64

Ticker: VKTX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	VKTX	32.16	0.19	0.27	231373
2026-08-31	VKTX	32.76	0.18	0.16	222613
2026-09-01	VKTX	33.67	0.18109337651322	0.28647329121195	229764
2026-09-02	VKTX	33.51	0.18	0.68	234785
2026-09-03	VKTX	33.99	0.19	0.60	237015
2026-09-04	VKTX	34.89	0.19	0.59	241472
2026-09-08	VKTX	33.67	0.20	0.31	234620
2026-09-09	VKTX	32.7	0.20	0.35	245097
2026-09-10	VKTX	32.17	0.21	0.47	264114
2026-09-11	VKTX	31.97	0.21	0.45	270970
2026-09-14	VKTX	31.52	0.20	0.46	255933
2026-09-15	VKTX	29.95	0.21	0.37	262206
2026-09-16	VKTX	29.53	0.20	0.14	271167
2026-09-17	VKTX	29.37	0.20	0.33	281493
2026-09-18	VKTX	28.97	0.20	0.67	287918
2026-09-21	VKTX	30.11	0.22	0.34	246607
2026-09-22	VKTX	40.79	0.23	0.39	292955
2026-09-23	VKTX	41.65	0.28	0.37	319020
2026-09-24	VKTX	36.75	0.29	0.27	330763
2026-09-25	VKTX	35.53	0.29	0.41	353111
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	VKTX	32.21	-31.5	24.4	-4.61
2026-08-31	VKTX	32.76	-31.5	-19.9	-4.61
2026-09-01	VKTX	33.70	-31.5	-25.6	-4.61
2026-09-02	VKTX	33.51	-31.5	-178.9	-4.61
2026-09-03	VKTX	33.97	-31.5	-194.9	-4.61
2026-09-04	VKTX	34.88	-31.5	-205.1	-4.61
2026-09-08	VKTX	33.69	-31.5	-154.4	-4.61
2026-09-09	VKTX	32.73	-31.5	-158.9	-4.61
2026-09-10	VKTX	32.15	-31.5	-168.7	-4.61
2026-09-11	VKTX	32.00	-31.5	-179.5	-4.61
2026-09-14	VKTX	31.52	-31.5	-170.6	-4.61
2026-09-15	VKTX	29.95	-31.5	-140.0	-4.61
2026-09-16	VKTX	29.95	-31.5	-140.0	-4.61
2026-09-17	VKTX	29.35	-31.5	-178.0	-4.61
2026-09-18	VKTX	28.96	-31.5	-171.1	-4.61
2026-09-21	VKTX	30.11	-31.5	-216.6	-4.61
2026-09-22	VKTX	40.87	-31.5	-492.2	-4.61
2026-09-23	VKTX	41.65	-31.5	-199.2	-4.61
2026-09-24	VKTX	36.75	-31.5	-85.6	-4.61
2026-09-25	VKTX	35.54	-31.5	-155.2	-4.61
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	VKTX	-4.70	2.12	19.73
2026-08-31	VKTX	-4.70	2.12	19.73
2026-09-01	VKTX	-4.70	2.12	19.73
2026-09-02	VKTX	-4.70	2.12	19.73
2026-09-03	VKTX	-4.70	2.12	19.73
2026-09-04	VKTX	-4.70	2.12	19.73
2026-09-08	VKTX	-4.70	2.10	19.73
2026-09-09	VKTX	-4.70	2.10	19.73
2026-09-10	VKTX	-4.70	2.10	19.73
2026-09-11	VKTX	-4.81	2.10	19.65
2026-09-14	VKTX	-4.81	2.14	19.65
2026-09-15	VKTX	-4.81	2.14	19.65
2026-09-16	VKTX	-4.81	2.14	19.65
2026-09-17	VKTX	-4.81	2.14	19.65
2026-09-18	VKTX	-4.81	2.14	19.65
2026-09-21	VKTX	-4.81	2.16	19.65
2026-09-23	VKTX	-4.81	2.16	19.65
2026-09-24	VKTX	-4.81	2.16	19.65
2026-09-25	VKTX	-4.81	2.16	20.00
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.1

Avg. EPS Est. Current Quarter

-1.07

Avg. EPS Est. Next Quarter

-1.1

Insider Transactions

-4.81

Institutional Transactions

2.16

Beta

0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.3

Max Drawdown 5-Year %

-78.9

Target Price

95.67

P/E

Forward P/E

PEG

P/S

P/B

10.16

P/Free Cash Flow

EPS

-4.66

Average EPS Est. Cur. Y

-4.61

EPS Next Y. (Est.)

-4.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

3.96

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-155.2

◆ VKTX Healthcare

$35.56

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

17/25

Volume

0/15

Valuation

10/20

TP/AR

2/10

Options

8/10

RSI

Range 1M

49.5%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

6/30

Estimates

0/20

Inst/Vol

8/15

Options

8/10

EPS Yr

-44.6%

EPS NY

4.8%

52W%

59.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +169% upside

Quality

2/30

Valuation

15/30

Growth

3/25

Stability

8/10

LT Trend

1/5

Upside

+169%

Quality

VKTX — P/E HistoricalBiotechnology

Viking Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 65

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

VKTX

Latest News

—

Caricamento notizie per VKTX…

stock quote shares VKTX – Viking Therapeutics Inc. Stock Price stock today

news today VKTX – Viking Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VKTX – Viking Therapeutics Inc. yahoo finance google finance

stock history VKTX – Viking Therapeutics Inc. invest stock market

stock prices VKTX premarket after hours

ticker VKTX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VKTX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y